Navigation Links
Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference
Date:2/29/2008

HAYWARD, Calif., Feb. 29 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) announced today that Gary S. Titus, Kosan's Senior Vice President and Chief Financial Officer, will present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference in New York at the W Hotel on Tuesday, March 4, 2008 at 10:30 a.m. EST. A live webcast of the presentation can be accessed through http://www.wsw.com/webcast/sig7/kosn/.

Interested parties may also access a live webcast of the presentation by visiting the "Events Calendar" page under the "Investors/Press" tab on Kosan's website at http://www.kosan.com. A recorded replay of the presentations will be available for two weeks.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with bortezomib (Velcade(R)) in patients with multiple myeloma in a clinical program called TIME. Tanespimycin is also being studied in HER2-positive metastatic breast cancer in combination with trastuzumab (Herceptin(R)). Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's motilin agonist compound, KOS-2187, licensed to Pfizer, is in a Phase 1 trial in gastroesophageal reflux disease
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
3. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
4. Kosan Biosciences to Host Research & Development Day on October 31, 2007
5. Kosan to Reacquire Epothilone Program From Roche
6. Kosan Announces Third Quarter 2007 Financial Results
7. Kosans Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer
8. Kosan Announces February 28, 2008 Conference Call and Webcast
9. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
10. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticals...hasallowedthepatentapplicationfor,itsnano-particle...sahighlyefficientapproachtoincorporatepeptidesor,p...eliveryofdrugs,otherwiseadministeredasinjections.N...tomanymacromoleculardrugssuchasinsulin,interferon,...
(Date:11/24/2009)...ATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.ann...mentAuthority(OPDA)wererecentlyawarded$2millionbyW...rd(CERB)inaprivate/publicpartnershiptoconstructthe...lnCounty,WA. ,, "Thisinvestmentwillsignificantl...greenjobstoLincolnCounty,"saidBlueMarbleEnergyCEOK...
(Date:11/24/2009)...XVENTURE:HTL , TORONTO,Nov.24/PRNewswire-Firs...toCapitalInc.,aleadingproviderofadvancedlasersyste...clinicmarkets,todayreportedoperationalandfinancial... ,Q32009Highlights,-Revenuewas$1.46millioncompare...3percentcomparedwith66.1percentinQ3,2008,-Netlossr...
(Date:11/24/2009)...DWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/--Gen...ndyScott,GenomicHealth,sExecutiveChairman,willpres...inNewYorkCityonTuesday,December1,2009at10:00a.m.ET...astofthepresentation,visittheInvestorRelationssect...michealth.com .Pleaseconnecttothewebsiteatleast15m...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2
...egic Selling Outlook Addresses Rapidly Changing Se...nd Sales Representatives , , LAMBERTVILLE, N.J., ...vider of market intelligence to the pharmaceutical...harmaceutical sales force effectiveness service un...ion and renamed the group Strategic Selling Outloo...
...ovide Overview of Pharmacy Benefit Management Accr...RAC , the leading health care accreditation and e...or of Pharmacy Programs Janice Anderson, RPh, has ...y of Managed Care Pharmacy (AMCP) Meeting , the l...sionals dedicated solely to the issues of managed ...
... SAN FRANCISCO, Calif., April 16 Proteolix, Inc. ... to the post of Senior Vice President, Finance and... (CFO), and the expansion of the company,s clinica...the appointment of Michael G. Kauffman, M.D., Ph.D...Albert L. Kraus, Ph.D., to the newly-created posit...
Other Biology Technology:Health Strategies Group Expands Focus of Pharma Sales Force Effectiveness Service Under New Vision and Name 2Health Strategies Group Expands Focus of Pharma Sales Force Effectiveness Service Under New Vision and Name 3URAC Director of Pharmacy Programs to Speak at Academy of Managed Care Pharmacy Annual Meeting 2URAC Director of Pharmacy Programs to Speak at Academy of Managed Care Pharmacy Annual Meeting 3Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team 2Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team 3Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team 4
(Date:11/24/2009)... , The Lupus Research Institute (LRI) today named...aling $3.6 million, recognize innovative work acro...lected for their creativity, novelty, and potentia...ent, treat, and cure the complex disease of system...stablished lupus researchers across the nation and...
(Date:11/24/2009)... , The atomic-level action of a remarkable class ...y researchers with the Lawrence Berkeley National ... protein crystallography beamline at the Advanced ...tal roles in gene expression and replication, and ... as well as infectious agents, such as the human p...
(Date:11/24/2009)... , What constitutes fish food is a matter of deb...d that fish get almost 50 percent of their carbon ...ink between the terrestrial and aquatic ecosystems...ington shows this is not likely to be true. Algae ...tic life, according to research published this wee...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Sangamo Announces Closing of Common Stock Offering 5433 1Sangamo Announces Closing of Common Stock Offering 5433 2Sangamo Announces Closing of Common Stock Offering 5433 3Pitt researchers find candidates for new HIV drugs 59378 1Pitt researchers find candidates for new HIV drugs 59378 2TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ 10341 1
...hildren who possess a gene known to increase the r...educed cognitive function, an Oregon Health & Scie...the OHSU School of Medicine discovered that 7- to ...plicated in development, nerve cell regeneration a...g and memory, associated with later-life cognitive...
... fresh green vegetables? Your answer tells a lot a... thousands of tiny worms have answered that questi...too. , In the experiment at the University of Roc...es (with characteristics of both females and males... other of the two sexes in these worms opted for ...
...attend the IOF World Congress on Osteoporosis 2008...w submit their registration to benefit from specia...e held from December 3-7, 2008, is the worlds larg...teoporosis. , Registration is available to IOF ... a reduced registration fee until May 22, 2008. On...
Other Biology News:Children with gene show reduced cognitive function 2Worms take the sniff test to reveal sex differences in brain 2Worms take the sniff test to reveal sex differences in brain 3
Alexa Fluor 350/488/594 Filter Set (Semrock Brightline) *mounted* *Zeiss Axio AF from Molecular Probes (Invitrogen)
Custom Conjugation Services from SoluLink
TMA Foresight from PREMIER Biosoft International from PREMIER Biosoft International
...upply, 1. 3500 V, 400 mA, 200 W maximum.Constant v...ar voltage ramp modes.Linear voltage ramp mode bri...quickly without danger of overheating.Volt-hour an... in gel thickness, sample ionic strength, and temp...
Biology Products: